OmniAb, Inc.

Business Wire•7/16/2026

OmniAb to Report Second Quarter 2026 Financial Results on August 6

OmniAb Names Amechi Nwachuku Chief Operating Officer

OmniAb, Inc. (NASDAQ: OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation therapeutics, announces that it

Business Wire•7/13/2026

OmniAb Names Amechi Nwachuku Chief Operating Officer

OmniAb Q1 Earnings Call Highlights

Zacks Investment Research•5/7/2026

OmniAb, Inc. (OABI) Reports Q1 Loss, Tops Revenue Estimates

OmniAb, Inc. (OABI) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.1. This compares to a loss of $0.17 per share a year ago.

Business Wire•5/7/2026

OmniAb Reports First Quarter 2026 Financial Results and Business Highlights

EMERYVILLE, Calif.--(BUSINESS WIRE)---- $OABI #OABI--OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the three months ended March 31, 2026, provided operating and partner program updates, and increased 2026 financial guidance. “OmniAb experienced strong momentum during the first quarter as multiple partnered programs advanced into later-stage clinical development, reinforcing the diversity and value of our portfolio. With a very strong start to the year, we are raising our 2026 revenue guidanc.